Saturn V Capital Management »

BioCryst Pharmaceuticals shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.0M 983k 7.08
2023-06-30 $6.7M 955k 7.04
2023-03-31 $9.7M 1.2M 8.34
2022-12-31 $3.8M 340k 11.03